Enhancing Prosthetic Joint Safety: How Isothermal Microcalorimetry is Making a Difference

In a recent publication in the Journal of Clinical Microbiology, a team of orthopedic surgeons compared the calScreener™ to traditional detection methods and found that it was possible to identify prosthetic joint infections from intraoperative...

Symcel Appoints Pia van der Zee as Chief Commercial Officer to Spearhead Growth in Emerging Clinical Markets

[STOCKHOLM, OCTOBER 2023] - Symcel, a leading medtech company transforming rapid infection diagnostics and microbial testing, is thrilled to announce the appointment of Pia van der Zee as its new Chief Commercial Officer (CCO). This strategic move...

Symcel Awarded Grant to Develop Fast Diagnostics for Joint Infections

We are thrilled to announce that Symcel has been awarded a grant to further develop fast diagnostics for prosthesis and joint infections. This exciting development represents a major step forward in our ongoing efforts to improve patient outcomes...

Welcome to the team - Kasper Nørskov Kragh

This week we are happy to welcome a brand new addition to the Symcel family, Kasper Kragh.

NEW PUBLICATION: Bacteria control their metabolism when going into biofilm formation

- This shift in metabolism has strong implications for tolerance to antibiotics

Invited to speak at the United States Pharmacopeia on probiotics

Today our Principal Scientist, Dr. Marta Veses Garcia will present at the United States Pharmacopeia event.

Symcel establishes US operation with headquarters in Boston

- The move brings Symcel closer to one of the world's biggest life science hubs